Patienter, der oplever mucositis (grad 2 eller værre) under behandling med Paxene, bør have deres dosis nedsat med 25% ved efterfølgende behandlinger med Paxene.
Patients who experience mucositis (Grade 2 or worse) during Paxene therapy should have their dosage reduced by 25% for subsequent courses of Paxene.